1 / 16

Pancreatic Enzyme Delivery (PED) Device

Pancreatic Enzyme Delivery (PED) Device. Group Members : Todd Dhavale Erica Osadzinski Advisor : Dr. Dennis C. Stokes Associate Prof. Pediatrics Pulmonary Medicine. What is Cystic Fibrosis (CF)? . 40,000 cases in the United States alone

zachery-dejesus
Télécharger la présentation

Pancreatic Enzyme Delivery (PED) Device

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pancreatic Enzyme Delivery (PED) Device Group Members: Todd Dhavale Erica Osadzinski Advisor: Dr. Dennis C. Stokes Associate Prof. Pediatrics Pulmonary Medicine

  2. What is Cystic Fibrosis (CF)? • 40,000 cases in the United States alone • 2,000 children are born with CF every year • Inherited disease which causes exocrine (outward secreting) glands in the body to fail to function normally. • Mucus-producing exocrine glands often produce thick, sticky secretions which plug-up ducts and other passageways. • This occurs in the lungs and intestines and interferes with breathing and digestion. • CF is not curable at this time

  3. Effects of Cystic Fibrosis on Digestion • Occurs in 8 out of 10 of all CF patients • Pancreatic enzymes do not reach intestinal tract • Malabsorption occurs • Patients do not gain weight --growth impairment • Therefore, above average caloric intake is needed along with supplemental enzymes • Our major concerns are these effects on infants with CF

  4. The Current Situation • Currently infants receive no supplemental enzymes • Supplemental enzymes are packaged in “microspheres” which are enclosed in capsules which infants are unable to swallow • Microspheres are made to protect the enzymes in the acidic environment of the stomach • Microspheres release and activate the enzymes in the alkaline small intestine so absorption can occur • Thus, there is a need for a device that can administer the microspheres to infants simultaneously with the formula

  5. Requested device parameters for infants and small children: • Eight hour night time feeding • Dr. Stokes prescribes: • 3-5 capsules (containing pancreatic enzyme microspheres) per night time feeding

  6. Our Solution: The PED Device • Delivers enzymes to infants receiving overnight supplemental feedings via a gastrostomy tube (G-tube)

  7. Components of the PED Device • Uses Creon brand microspheres suspended in fluid delivery vehicle, Ora-Plus

  8. Components of the PED Device • The vehicle-microsphere mixture is continuously pumped into the G-tube • where it will be combined with the formula via a ‘Y’ connector, • then enter the stomach

  9. Alternate Solutions??? • Pre-mixing microspheres in formula? • intact • crushed • Dry, Without Suspending Vehicle? • air • gravity deposit in formula

  10. Implementing and testing our solution: • 1) Researched pancreatic enzymes function • 2) Assessed the current methods of obtaining the necessary pancreatic enzymes • 3) Met with pharmacist and pediatric nurse for advice and recommendations • 20-25mLlimit volume forOra-Plus

  11. 4) Which Microspheres worked best? • Tested microsphere stability in the fluid delivery vehicle: • Pancrecarb MS-8 had too large of Microspheres • Pancrecarb MS-4 had the smallest Microspheres • But the Pancrecarb brand proved to be unstable in the Ora-Plus… • Thus these Microspheres broke down before reaching the stomach Creon Pancrecarb MS-4 Pancrecarb MS-8

  12. 5) Our Choice: Creon Brand microspheres • Creon brand Microspheres are slightly larger than the smallest, Pancrecarb MS-4 • Creon proved to remain stable in the Ora-Plus for around 8 hours, (over-night) • Pancrecarb only remained stable for a mere 1 hour

  13. 6) PED Pump Requirements • Need 20-25mL of fluid vehicle for overnight feeding • For 3-5 Creon 5 Capsules over 8 hour period: • 20 mL / 8 Hrs = 2.5 mL/Hr • 5 capsules / 20 mL = 1 capsule / 4 mL

  14. 7) Which Pump works better? • Delivers the minimum fluid vehicle volume necessary for overnight enzyme delivery: • Syringe • Peristaltic • Our Choice: • SYRINGE PUMP • WHY?

  15. 8) Other factors • Integrate pump fittings with connectors to gastrostomy tube (G-Tube) • DesignSafe Analysis

  16. Future Work: • Improve the current crude PED model: • Solvay Pharmaceutical Funding? • Self-contained device • Out-Patient Use

More Related